191 related articles for article (PubMed ID: 36985814)
1. Antileishmanial Activity of Cinnamic Acid Derivatives against
de Morais MC; Medeiros GA; Almeida FS; Rocha JDC; Perez-Castillo Y; Keesen TSL; de Sousa DP
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985814
[No Abstract] [Full Text] [Related]
2. Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
Reis TAR; Oliveira-da-Silva JA; Tavares GSV; Mendonça DVC; Freitas CS; Costa RR; Lage DP; Martins VT; Machado AS; Ramos FF; Silva AM; Ludolf F; Antinarelli LMR; Brito RCF; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Coimbra ES; Coelho EAF
Exp Parasitol; 2021 Feb; 221():108059. PubMed ID: 33338468
[TBL] [Abstract][Full Text] [Related]
3. Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.
Freitas CS; Oliveira-da-Silva JA; Lage DP; Costa RR; Mendonça DVC; Martins VT; Reis TAR; Antinarelli LMR; Machado AS; Tavares GSV; Ramos FF; Coelho VTS; Brito RCF; Ludolf F; Chávez-Fumagalli MA; Roatt BM; Ramos GS; Munkert J; Ottoni FM; Campana PRV; Humbert MV; Coimbra ES; Braga FC; Pádua RM; Coelho EAF
Parasitol Res; 2021 Jan; 120(1):321-335. PubMed ID: 33191446
[TBL] [Abstract][Full Text] [Related]
4. In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative.
de Almeida L; Passalacqua TG; Dutra LA; Fonseca JNVD; Nascimento RFQ; Imamura KB; de Andrade CR; Dos Santos JL; Graminha MAS
Biomed Pharmacother; 2017 Nov; 95():536-547. PubMed ID: 28866421
[TBL] [Abstract][Full Text] [Related]
5. Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.
Lage PS; Chávez-Fumagalli MA; Mesquita JT; Mata LM; Fernandes SO; Cardoso VN; Soto M; Tavares CA; Leite JP; Tempone AG; Coelho EA
Parasitol Res; 2015 Dec; 114(12):4625-35. PubMed ID: 26346453
[TBL] [Abstract][Full Text] [Related]
6. Substituted 1,5-naphthyridine derivatives as novel antileishmanial agents. Synthesis and biological evaluation.
Tejería A; Pérez-Pertejo Y; Reguera RM; Balaña-Fouce R; Alonso C; González M; Rubiales G; Palacios F
Eur J Med Chem; 2018 May; 152():137-147. PubMed ID: 29704722
[TBL] [Abstract][Full Text] [Related]
7. Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB.
Pérez-Pertejo Y; Escudero-Martínez JM; Reguera RM; Balaña-Fouce R; García PA; Jambrina PG; San Feliciano A; Castro MÁ
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():70-79. PubMed ID: 31678841
[TBL] [Abstract][Full Text] [Related]
8. Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
Pereira IAG; Mendonça DVC; Tavares GSV; Lage DP; Ramos FF; Oliveira-da-Silva JA; Antinarelli LMR; Machado AS; Carvalho LM; Carvalho AMRS; Salustiano IV; Reis TAR; Bandeira RS; Silva AM; Martins VT; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Duarte MC; Menezes-Souza D; Coimbra ES; Leite JPV; Coelho EAF; Gonçalves DU
Parasite Immunol; 2020 Dec; 42(12):e12784. PubMed ID: 32772379
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
10. Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
Costa RR; Oliveira-da-Silva JA; Reis TAR; Tavares GSV; Mendonça DVC; Freitas CS; Lage DP; Martins VT; Antinarelli LMR; Machado AS; Bandeira RS; Ludolf F; Santos TTO; Brito RCF; Humbert MV; Menezes-Souza D; Duarte MC; Chávez-Fumagalli MA; Roatt BM; Coimbra ES; Coelho EAF
Med Microbiol Immunol; 2021 Jun; 210(2-3):133-147. PubMed ID: 33870453
[TBL] [Abstract][Full Text] [Related]
11. Cinnamic Acid Bornyl Ester Derivatives from Valeriana wallichii Exhibit Antileishmanial In Vivo Activity in Leishmania major-Infected BALB/c Mice.
Masic A; Valencia Hernandez AM; Hazra S; Glaser J; Holzgrabe U; Hazra B; Schurigt U
PLoS One; 2015; 10(11):e0142386. PubMed ID: 26554591
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-leishmanial evaluation of 1-phenyl-2,3,4,9-tetrahydro-1H-β-carboline derivatives against Leishmania infantum.
Ashok P; Chander S; Tejería A; García-Calvo L; Balaña-Fouce R; Murugesan S
Eur J Med Chem; 2016 Nov; 123():814-821. PubMed ID: 27541264
[TBL] [Abstract][Full Text] [Related]
13. Antileishmanial effect of new indeno-1,5-naphthyridines, selective inhibitors of Leishmania infantum type IB DNA topoisomerase.
Tejería A; Pérez-Pertejo Y; Reguera RM; Balaña-Fouce R; Alonso C; Fuertes M; González M; Rubiales G; Palacios F
Eur J Med Chem; 2016 Nov; 124():740-749. PubMed ID: 27639365
[TBL] [Abstract][Full Text] [Related]
14. Functionalized 1,2,3-triazolium salts as potential agents against visceral leishmaniasis.
das Chagas Almeida A; Meinel RS; Leal YL; Silva TP; Glanzmann N; Mendonça DVC; Perin L; Cunha-Júnior EF; Coelho EAF; Melo RCN; da Silva AD; Coimbra ES
Parasitol Res; 2022 May; 121(5):1389-1406. PubMed ID: 35169883
[TBL] [Abstract][Full Text] [Related]
15. In vitro antileishmanial activity of leaf and stem extracts of seven Brazilian plant species.
de Paula RC; da Silva SM; Faria KF; Frézard F; Moreira CPS; Foubert K; Lopes JCD; Campana PRV; Rocha MP; Silva AF; Silva CG; Pieters L; Almeida VL
J Ethnopharmacol; 2019 Mar; 232():155-164. PubMed ID: 30580025
[TBL] [Abstract][Full Text] [Related]
16. Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment.
Henriquez-Figuereo A; Moreno E; Sanmartin C; Plano D
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570815
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Antileishmanial Activity and
de Aquino TM; França PHB; Rodrigues ÉEES; Nascimento IJS; Santos-Júnior PFS; Aquino PGV; Santos MS; Queiroz AC; Araújo MV; Alexandre-Moreira MS; Rodrigues RRL; Rodrigues KAF; Freitas JD; Bricard J; Meneghetti MR; Bourguignon JJ; Schmitt M; da Silva-Júnior EF; de Araújo-Júnior JX
Med Chem; 2022; 18(2):151-169. PubMed ID: 33593264
[TBL] [Abstract][Full Text] [Related]
18. Antileishmanial Activities of Medicinal Herbs and Phytochemicals In Vitro and In Vivo: An Update for the Years 2015 to 2021.
Hassan AA; Khalid HE; Abdalla AH; Mukhtar MM; Osman WJ; Efferth T
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364404
[TBL] [Abstract][Full Text] [Related]
19. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
[TBL] [Abstract][Full Text] [Related]
20. The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis.
Pal R; Teli G; Akhtar MJ; Matada GSP
Eur J Med Chem; 2023 Oct; 258():115609. PubMed ID: 37421889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
